Reuters logo
BRIEF-Janssen provides Nuevolution with further technology access fee payment
March 6, 2017 / 7:41 AM / 7 months ago

BRIEF-Janssen provides Nuevolution with further technology access fee payment

March 6 (Reuters) - Nuevolution AB (publ):

* Nuevolution announces further technology access fee payment from its drug discovery collaboration with Janssen Biotech, Inc. (Janssen)

* Janssen, one of pharmaceutical companies of Johnson & Johnson, has used its option to expand collaboration with Nuevolution

* Janssen has provided Nuevolution with technology access fee payment of $0.6 million (5.45 million Swedish crowns)

Source text for Eikon:

Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below